Brief: Sangamo Therapeutics Q2 EPS USD -0.18 Vs. IBES Estimate USD -0.15

Sangamo Therapeutics

06/08/2024 21:01

Aug 06 (Reuters) - Sangamo Therapeutics Q2 net income USD -36.128 million.
* Q2 adjusted operating expenses USD 31.9 million
* Q2 operating expenses USD 37.4 million
* Q2 revenue USD 356 thousand vs. IBES estimate USD 8.26 million
* Q2 operating income USD -37.084 million